UNSPSC 41132006: Plasma derivatives or isolated clotting factors

Cryopoor plasma, Factors 8, 9,

UNSPSC 41132006 Plasma derivatives or isolated clotting factors is a Commodity code covering blood products and related transfusion services that state and local hospital systems and medical centers procure to support inpatient and outpatient care. State and local public health entities, county hospital authorities, and medical centers issue solicitations under this code for supplies of whole blood components—principally red blood cells, fresh frozen plasma, platelets, and cryoprecipitate—along with associated immunohematology and reference laboratory services. Vendors must hold FDA, CLIA, and AABB certifications; maintain state licensure to collect, process, and distribute blood products; and carry general liability, professional liability, and workers' compensation insurance meeting or exceeding specified thresholds. Five-year prior experience providing similar services is a baseline qualification threshold. Contracting entities typically apply local-business preferences when available, impose living-wage requirements, enforce HIPAA compliance for protected health information, and require vendors to register with SAM.gov and maintain non-debarred status from federal and state health-care programs.

The County of San Mateo issued an RFP for blood products and blood services in support of San Mateo Medical Center on July 24, 2026, with responses due August 28, 2026, incorporating a 5 to 10 percentage point local-business preference and requiring twice-daily delivery Monday through Friday and once-daily delivery on weekends. Anticipated annual volumes based on 2025 usage include 888 units of red blood cells, 85 units of single-donor platelets, 49 units of fresh frozen plasma, and 8 units of pooled cryoprecipitate; the contract term is five years with award on a best-value basis. No pre-proposal conference or site visit was scheduled, and no incumbent was identified in the solicitation. The source reflects a single recent opportunity; geographic distribution and patterns of repeat buyers across other jurisdictions are not supported by the available data.